Hofmann Ilona, Wunderlich Nina, Robertson Greg, Kieback Arno, Haller Christlieb, Pfeil Wolfgang, Störk Thomas, Hoffmann Gerhard, Bischoff Karl-Otto, Dorsel Thomas, Görge Günter, Sievert Horst
CardioVascular Center, Sankt Katharinen Hospital, Frankfurt/Main, Germany.
EuroIntervention. 2007 Nov;3(3):321-6. doi: 10.4244/eijv3i3a59.
False aneurysms can be treated surgically or by ultrasound guided manual compression. Another method is to inject thrombin into the aneurysm under ultrasound guidance. We evaluated safety and efficacy of this approach in a multicentre registry.
In 595 consecutive patients a pseudoaneurysm (593 femoral arteries, 2 brachial arteries) was diagnosed 0 to 250 days (median 3 days) after a catheter procedure. The diameter of the aneurysm ranged from 0.5x0.5x0.5 (LxWxD) to 8x11x16 cm (median 2x2x1.6 cm). 20 U to 4000 U (median 400 U) of thrombin solution were injected into the aneurysm under ultrasound guidance.The procedure was technically successful in 587/595 (99%) patients.The aneurysms were thrombosed after the first injection in 531 (89%) patients. Thirty-eight (6%) patients needed a second injection and eight (1%) patients, a third injection because residual flow in the aneurysm was visible at follow-up. In four (0.7%) additional patients the thrombosis of the aneurysms was delayed and occurred only after 24 hours to seven days. Six (1%) patients surgery was performed after successful closure of the aneurysm to remove the resulting haematoma. The overall technical success rate was 99% and clinical success was achieved in 96%.Eight (1%) other patients underwent surgery due to thrombin injection failure.Complications occurred in nine patients (1,5%). Intravascular thrombus formation, deep venous thrombosis, pulmonary embolism due to deep venous thrombosis, transient paresthesia in the leg during injection.
Ultrasound guided thrombin injection is a safe, effective and rapid treatment of false aneurysms. Complications and recurrent pseudoaneurysms are rare.
假性动脉瘤可通过手术治疗或超声引导下手动压迫治疗。另一种方法是在超声引导下将凝血酶注入动脉瘤内。我们在一个多中心登记处评估了这种方法的安全性和有效性。
在595例连续患者中,在导管操作后0至250天(中位数3天)诊断出假性动脉瘤(593例为股动脉,2例为肱动脉)。动脉瘤直径范围为0.5×0.5×0.5(长×宽×深)至8×11×16厘米(中位数2×2×1.6厘米)。在超声引导下将20单位至4000单位(中位数400单位)的凝血酶溶液注入动脉瘤内。该操作在587/595(99%)例患者中技术成功。531例(89%)患者在首次注射后动脉瘤形成血栓。38例(6%)患者需要第二次注射,8例(1%)患者需要第三次注射,因为随访时可见动脉瘤内有残余血流。另外4例(0.7%)患者动脉瘤血栓形成延迟,仅在24小时至7天后发生。6例(1%)患者在动脉瘤成功闭合后进行手术以清除形成的血肿。总体技术成功率为99%,临床成功率为96%。另外8例(1%)患者因凝血酶注射失败接受手术。9例患者(1.5%)出现并发症。血管内血栓形成、深静脉血栓形成、深静脉血栓形成导致的肺栓塞、注射时腿部短暂感觉异常。
超声引导下凝血酶注射是一种安全、有效且快速的假性动脉瘤治疗方法。并发症和复发性假性动脉瘤罕见。